{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:59:52Z","timestamp":1793408392718,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.vaccine.2020.09.004","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T23:41:00Z","timestamp":1610062860000},"page":"A24-A35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"S1","title":["Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-607X","authenticated-orcid":false,"given":"Jason K.H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine I.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Chit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2020.09.004_b0005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2020.09.004_b0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cis211","article-title":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993\u20132008","volume":"54","author":"Zhou","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.004_b0015","unstructured":"Centers for Disease Control and Prevention. Disease burden of influenza. Accessed 1 November 2019. https:\/\/www.cdc.gov\/flu\/about\/disease\/burden.htm."},{"key":"10.1016\/j.vaccine.2020.09.004_b0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(14)71087-4","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.004_b0025","article-title":"Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017\u20132018","author":"Izurieta","year":"2018","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.09.004_b0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14760584.2018.1471989","article-title":"Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2018","journal-title":"Expert review of vaccines."},{"issue":"1","key":"10.1016\/j.vaccine.2020.09.004_b0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing seasonal influenza\u2014the need for a universal influenza vaccine","volume":"378","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.09.004_b0040","unstructured":"Transparent Reporting of Systematic Reviews and Meta-Analyses. Ottawa Hospital Research Institute and University of Oxford. Available at: http:\/\/prisma-statement.org\/Default.aspx Accessed 1 Nov 2018."},{"key":"10.1016\/j.vaccine.2020.09.004_b0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2020.09.004_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2020.09.004_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2020.09.004_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.09.004_b0065","unstructured":"Random-effects (DerSimonian and Laird) method for meta-analysis. Cochrane Handbook. Available at. Accessed 01 November 2019. http:\/\/handbook.cochrane.org\/chapter_9\/9_4_3_1_random_effects_dersimonian_and_laird_method_for.htm."},{"key":"10.1016\/j.vaccine.2020.09.004_b0070","unstructured":"Sanofi Pasteur. A Study of Fluzone\u00ae High-Dose Vaccine Compared with Fluzone\u00ae Vaccine in Elderly Adults. Available from. NLM identifier: NCT01427309. Accessed May 31, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01427309."},{"key":"10.1016\/j.vaccine.2020.09.004_b0075","unstructured":"Centers for Disease Control and Prevention. FluView Interactive. Available at: http:\/\/gis.cdc.gov\/grasp\/fluview\/fluportaldashboard.html. Accessed 01 May 2020."},{"key":"10.1016\/j.vaccine.2020.09.004_b0080","unstructured":"Centers for Disease Control and Prevention (CDC. Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR. Morbidity and mortality weekly report. 2011 Jun 3;60(21):705."},{"key":"10.1016\/j.vaccine.2020.09.004_b0085","unstructured":"Centers for Disease Control and Prevention (CDC. Update: influenza activity-United States, 2011-12 season and composition of the 2012-13 influenza vaccine. MMWR. Morbidity and mortality weekly report. 2012 Jun 8;61(22):414."},{"issue":"23","key":"10.1016\/j.vaccine.2020.09.004_b0090","first-page":"473","article-title":"Influenza activity\u2014United States, 2012\u201313 season and composition of the 2013\u201314 influenza vaccine","volume":"62","author":"Brammer","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2020.09.004_b0095","first-page":"483","article-title":"Influenza activity\u2014United States, 2013\u201314 season and composition of the 2014\u201315 influenza vaccines","volume":"63","author":"Epperson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.vaccine.2020.09.004_b0100","first-page":"583","article-title":"Influenza activity\u2014United States, 2014\u201315 season and composition of the 2015\u201316 influenza vaccine","volume":"64","author":"Appiah","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.09.004_b0105","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6522a3","article-title":"Influenza activity\u2014United States, 2015\u201316 season and composition of the 2016\u201317 influenza vaccine","volume":"65","author":"Davlin","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"10.1016\/j.vaccine.2020.09.004_b0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.15585\/mmwr.mm6625a3","article-title":"Update: influenza activity in the United States during the 2016\u201317 season and composition of the 2017\u201318 influenza vaccine","volume":"66","author":"Blanton","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2020.09.004_b0115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.15585\/mmwr.mm6722a4","article-title":"Update: influenza activity in the United States during the 2017\u201318 season and composition of the 2018\u201319 influenza vaccine","volume":"67","author":"Garten","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2020.09.004_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.15585\/mmwr.mm6824a3","article-title":"Update: influenza activity in the United States during the 2018\u201319 season and composition of the 2019\u201320 influenza vaccine","volume":"68","author":"Xu","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.09.004_b0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/jiw641","article-title":"Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012\u20132013 and 2013\u20132014","volume":"215","author":"Shay","year":"2017","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2020.09.004_b0130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/infdis\/jiz360","article-title":"Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged\u2265 65 Years","volume":"220","author":"Lu","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.004_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa080","article-title":"Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018\u20132019","author":"Izurieta","year":"2020","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.09.004_b0140","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.vaccine.2019.01.063","article-title":"Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method","volume":"37","author":"Young-Xu","year":"2019","journal-title":"Vaccine."},{"issue":"32","key":"10.1016\/j.vaccine.2020.09.004_b0145","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.vaccine.2019.06.066","article-title":"Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease","volume":"37","author":"van Aalst","year":"2019","journal-title":"Vaccine."},{"issue":"29","key":"10.1016\/j.vaccine.2020.09.004_b0150","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1016\/j.vaccine.2020.05.020","article-title":"Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population","volume":"38","author":"Paudel","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.09.004_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012\u201313 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS ONE"},{"issue":"47","key":"10.1016\/j.vaccine.2020.09.004_b0160","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2020.09.004_b0165","doi-asserted-by":"crossref","unstructured":"Skowronski DM, Chambers C, De Serres G, Dickinson JA, Winter AL, Hickman R, Chan T, Jassem AN, Drews SJ, Charest H, Gubbay JB. Early season co-circulation of influenza A (H3N2) and B (Yamagata): interim estimates of 2017\/18 vaccine effectiveness, Canada, January 2018. Eurosurveillance. 2018 Feb 1;23(5).","DOI":"10.2807\/1560-7917.ES.2018.23.5.18-00035"},{"key":"10.1016\/j.vaccine.2020.09.004_b0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.09.004_b0175","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.vaccine.2012.12.013","article-title":"High-dose trivalent influenza vaccine compared to standard-dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009\u20132010 season","volume":"31","author":"DiazGranados","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.004_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy088","article-title":"Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients","author":"Young-Xu","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.004_b0185","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2015.07.006","article-title":"Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.004_b0190","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial","volume":"5","author":"Gravenstein","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2020.09.004_b0195","first-page":"1","article-title":"Feasibility of a cluster-randomized influenza vaccination trial in US nursing homes: Lessons learned","volume":"1","author":"Gravenstein","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.09.004_b0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cid\/civ261","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans","volume":"61","author":"Richardson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2020.09.004_b0205","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1016\/j.vaccine.2018.09.050","article-title":"Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design","volume":"36","author":"Robison","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.004_b0210","article-title":"Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults\u2014United States, 2015\u20132017","author":"Doyle","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2020.09.004_b0215","doi-asserted-by":"crossref","first-page":"1900401","DOI":"10.2807\/1560-7917.ES.2020.25.19.1900401","article-title":"High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012\/13 to 2014\/15","volume":"25","author":"Young-Xu","year":"2020","journal-title":"Eurosurveillance."},{"issue":"2","key":"10.1016\/j.vaccine.2020.09.004_b0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2020.09.004_b0225","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.09.004_b0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/CVI.00604-15","article-title":"Correlates of protection against influenza in the elderly: results from an influenza vaccine efficacy trial","volume":"23","author":"Dunning","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.09.004_b0235","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.vaccine.2019.11.041","article-title":"Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent","volume":"38","author":"Gao","year":"2020","journal-title":"Vaccine."},{"issue":"8","key":"10.1016\/j.vaccine.2020.09.004_b0240","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2020.09.004_b0245","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/cid\/civ547","article-title":"Regarding primary care patients who received influenza vaccine at veteran health administration medical centers","volume":"61","author":"Decker","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:07Z","timestamp":1759402387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20311464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"alternative-id":["S0264410X20311464"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}